Form 4/A for CTOR CITIUS ONCOLOGY, INC.
Accepted 2025-12-01 00:00:00 ET · period of report 2025-09-19 · accession 0001213900-25-116678 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-12-01 | 2025-09-19 | CTOR | HOLUBIAK MYRON Z | Sec, Dir | A - Grant | $0.00 | +850.0K | 850.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-19 | A | A | 850,000 | $0.00 | 850,000 | D | — | — | (F1) Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date. |